Venus Concept Inc (OQ:VERO)

Business Focus: Advanced Medical Equipment & Technology

Jul 16, 2020 07:30 am ET
Venus Concept Reports Preliminary Revenue Results for Second Quarter 2020
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today reported preliminary revenue results for the three months ended June 30, 2020. Management Commentary: “While our second...
Jul 01, 2020 04:05 pm ET
Venus Concept Inc. Announces FDA 510(k) Clearance for Venus Viva MD
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received FDA 510(k) clearance to market and sell Venus Viva MD. Venus Viva MD is a non-invasive device...
Jun 26, 2020 07:30 am ET
Venus Concept Inc. Joins Russell 2000®, Russell 3000® and Russell Microcap® Indexes
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that the Company has been added to the Russell 2000®, Russell 3000® and Russell Microcap® Indexes. The Company’s...
Jun 25, 2020 04:05 pm ET
Venus Concept to Release Second Quarter of Fiscal Year 2020 Financial Results on August 13, 2020
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that second quarter of fiscal year 2020 financial results will be released after the market closes on Thursday, August 13,...
Jun 16, 2020 05:21 pm ET
Venus Concept Inc. Announces Common Stock Purchase Agreement for up to $31 Million with Lincoln Park Capital Fund, LLC
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has entered into a common stock purchase agreement for up to $31 million with Lincoln Park Capital Fund, LLC...
Jun 15, 2020 07:30 am ET
Venus Concept Inc. Announces FDA 510(k) Clearance for Venus Epileve
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received FDA 510(k) clearance to market and sell Venus Epileve. It is intended for treatment of hair...
May 14, 2020 04:05 pm ET
Venus Concept Announces First Quarter of 2020 Financial Results
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three months ended March 31, 2020. The Company notes that the financial results provided for the...
Apr 15, 2020 04:05 pm ET
Venus Concept to Release First Quarter of Fiscal Year 2020 Financial Results on May 14, 2020
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that first quarter of fiscal year 2020 financial results will be released after the market closes on Thursday, May 14,...
Mar 30, 2020 04:05 pm ET
Venus Concept Announces Fourth Quarter and Fiscal Year 2019 Financial Results; Provides Preliminary First Quarter of 2020 Revenue Results and Updates Fiscal Year 2020 Revenue Guidance
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three months and twelve months ended December 31, 2019 and preliminary revenue results for the...
Mar 18, 2020 04:05 pm ET
Venus Concept Inc. Announces $22.25 Million Equity Financing
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it entered into a definitive agreement for the sale of shares of its common stock, Series A convertible...
Mar 10, 2020 04:01 pm ET
Venus Concept to Release Fourth Quarter and Fiscal Year 2019 Financial Results on March 30, 2020
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that fourth quarter and fiscal year 2019 financial results will be released after the market closes on Monday, March 30....
Mar 03, 2020 07:05 am ET
Venus Concept Expands Executive Team
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that it has expanded its Executive Team with the appointment of Chad A. Zaring to the newly-created role of Chief...
Feb 14, 2020 04:05 pm ET
Venus Concept Inc. Announces New Regulatory Clearances
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received CE Mark approval to market Venus Bliss for non-invasive lipolysis of the abdomen and flanks,...
Jan 13, 2020 07:00 am ET
Venus Concept Announces Preliminary Fourth Quarter and Fiscal Year 2019 Revenue Results; Introduces Fiscal Year 2020 Revenue Guidance
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced preliminary unaudited revenue results for the three months and twelve months ended December 31, 2019 and introduced...
Dec 05, 2019 07:00 am ET
Venus Concept Inc. Announces CE Mark and Australian Regulatory Approval for NeoGraft 2.0, A Trusted Name in Hair Restoration
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received a CE Mark from DEKRA Certification B.V. and Therapeutic Goods Administration (TGA) clearance in...
Nov 26, 2019 07:05 am ET
Venus Concept Inc. Announces CE Mark and Health Canada License to Market Venus Epileve
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received a medical device license issued by Health Canada and CE Mark from DEKRA Certification B.V. to...
Nov 19, 2019 04:40 pm ET
Venus Concept Receives Health Canada Authorization to Market Venus Bliss in Canada
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received a medical device license issued by Health Canada to market Venus Bliss™, a medical aesthetic...
Nov 14, 2019 04:07 pm ET
Venus Concept Announces Third Quarter and First Nine Months of 2019 Financial Results
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, provided standalone Venus Concept, Ltd. financial results for the third quarter and nine months ended September 30, 2019. The...

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.